Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5165458 | 6125082 | F | 3 | 5165458-1 | 20060726 | 20061114 | 20061120 | EXP | 200610244BBE | TALECRIS BIOTHERAPEUTICS, INC. | 51 | YR | F | N | 128 | LBS | 20061117 | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5165458 | 1007911961 | PS | PROLASTIN | 1 | INTRAVENOUS | 3700 MG, TOTAL DAILY, INTRAVEOUS | D | D | 26N76C1 | 20090324 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 5165458 | 1007911961 | ALPHA-1 ANTI-TRYPSIN DEFICIENCY |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 5165458 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 5165458 | BONE MARROW FAILURE |
| 5165458 | LYMPHADENOPATHY |
| 5165458 | PLATELET COUNT DECREASED |
| 5165458 | VIRAL INFECTION |
| 5165458 | WHITE BLOOD CELL COUNT DECREASED |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 5165458 | HP |
| 5165458 | OTH |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 5165458 | 1007911961 | 20060726 |